Method for lowering plasma levels of lipoprotein(a)

Details Method for lowering plasma levels of lipoprotein(a) Method for lowering plasma levels of lipoprotein(a)

1996-06-03

1998-05-05

Jordan, Kimberly

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514422, 514824, 514866, A61K 31445, A61K 3140

Patent

active

057475091

ABSTRACT:
A method of lowering plasma levels of Lp(a) or inhibiting the generation of apo(a) in a human by administering an effective amount of a compound of the formula: ##STR1## wherein n is 0, 1 or 2:

REFERENCES:
patent: 4133814 (1979-01-01), Jones et al.
patent: 4418068 (1983-11-01), Jones
patent: 5489611 (1996-02-01), Lee et al.
patent: 5496828 (1996-03-01), Cullinan
patent: 5496851 (1996-03-01), Grinnell
CA 123:152916, Zuckerman, 1995.
CA 123:962, Cullinan et al., 1995.
Frazer, K. et al., Nature Genetics (1995) 9:424-431.
Kim et al., Arteriosclerosis and Thrombosis (1994) 14(2):275-281.
Brown et al., Arteriosclerosis Thromb (1993).
Anwar et al. (1993) Nephrol. Dial. Transplant. 8:71-74.
Heller et al., Diabetes Care (1993) 16(5):819-823.
Crook et al., Atherosclerosis (1992) 92:41-47.
Radar et al., JAMA (1992) 267(8):1109-1112.
Boerwinkle et al., J. Clin. Invest. (1992) 90:52-60.
Lawn et al., Nature (1992) 360: 670-672.
Muller et al., German J. Opthalmol (1992) 1:338-341.
Tyrell et al., J. of Int. Medicine, (1992) 232:349-352.
Kapelrud et al., Br. Med. J. (1991) 303:675-678.
Mosca, et al., Circulation (1991) 84(4), Suppl II: 2169.
Muesing et al., Arteriosclerosis Thromb. (1991) 11(5):1452(a).
Farish et al., Br. Med J. (1991) 303:694.
Meilahn et al., Circulation (1991) 84(4), Suppl. II: 2170 (abstract).
Srinivasan, et al., Circulation (1991) 84(1):160-167.
Scanu et al., J. Clin. Invest. (1990) 85:1709-1715.
Bruckert et al., JAMA (1990) 263(1):35-36.
Sandkamp et al., Academic Press, Inc. (1990) 205-210.
Davis et al., C.V.D. (1990) 25 (abstract).
Utermann, Science (1989) 246:904-910.
Hajjar et al., Nature (1989) 339;303-305.
Harpel et al., Proc. Natl. Acad. Sci. USA (1989) 86:3847-3851.
Kraft et al., J. Clin. Invest. (1989) 83:137-142.
Tomlinson et al., J. Biol. Chem. (1989) 264(10):5957-5965.
Scanu, Arch. Pathol. Lab. Med. (1988) 112:1045-1047.
Hoff et al., Circulation (1988) 77:1238-1244.
Karadi et al., Biochim. Biophys. Acta (1988) 960:91-97.
McLean et al., Nature (1987) 330:132-137.
Rhoades, et al., JAMA (1986) 256(18):2540-2544.
Dahlen et al., Circulation (1986) 74(4):758-765.
Armstrong et al., Atherosclerosis (1986) 62:249-257.
Zechner et al., Metabolism (1986) 35:333-336.
Schriewer et al., J. Clin. Chem. Clin. Biochem. (1984) 22:591-596.
Albers et al., Biochem. Biophys. Acta (1984) 795:293-296.
Kostner, Atherosclerosis (1981) 38:51-61.
Krempler et al., J. Clin. Invest. (1980) 65:148301490.

Affiliated with

Also associated with

Rating

Method for lowering plasma levels of lipoprotein(a) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for lowering plasma levels of lipoprotein(a), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for lowering plasma levels of lipoprotein(a) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-55052